Thursday, May 10, 2012
Rosenstiel Medical Sciences Building, fifth floor auditorium
From HIV HAART to Anti-Tumor Therapy
Nathalie McKenzie, M.D.
Fellow, Division of Gynecologic Oncology
University of Miami Miller School of Medicine
At the conclusion of the presentation, participants will:
1. Examine how HIV protease inhibiors exhibit anti-tumor effects.
2. Relation between P13K/Akt signaling pathway and cervical cancer.
3. Explain factors that play a role in cervical tumor’s resistance to radiation.
4. Examine how Nelfinavir (an HIV protease inhibitor) acts as a radiation sensitizer.
Dr. McKenzie has not indicated any relevant financial relationships with commercial interests.
PLANNING COMMITTEE DISCLOSURE
Drs. Diaz, Diro, and Stine have indicated that they have no relevant financial relationships with commercial interests.
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For additional information please contact Tameka Collins at (305) 585-5586.